Randomized study of once-weekly interferon β-la therapy in relapsing multiple sclerosis: Three-year data from the OWIMS study

Mark S. Freedman, G. S. Francis, E. A.C.M. Sanders, G. P.A. Rice, P. O'Connor, G. Comi, P. Duquette, L. Metz, T. J. Murray, J. P. Bouchard, O. Abramsky, J. Pelletier, F. O'Brien, J. de Rijk van Andel, J. P. Story, M. de Milliano, G. Ebers, J. Lesaux, K. Kennedy, P. HoustonJ. Hall, V. Martinelli, G. Santuccio, A. Poggi, M. Gironi, L. Moiola, G. Pepin, J. Poirer, G. Bernier, R. Dubois, R. Bell, D. McGowan, A. Demchuk, E. Harris, M. Yeung, A. Murphy, V. Bhan, C. Maxner, P. Weldon, L. Armstrong, F. Gosselin, M. Thibaut, L. Korouac, A. Morin, D. Karussis, A. Karni, M. Mor, R. Nelson, S. Christie, H. Rabonivitch, C. Freedman, M. Benavente, P. Bensa, A. Dalesky, D. Paty, D. Li, B. Rhodes, A. Riddehough, G. Zhao, X. Wang, Y. Chang, N. Ammoury, A. Galazka, R. Hyde, S. Shah, G. Francis, S. Shahid

Research output: Contribution to journalArticlepeer-review

41 Citations (Scopus)
Original languageEnglish
Pages (from-to)41-45
Number of pages5
JournalMultiple Sclerosis
Volume11
Issue number1
DOIs
Publication statusPublished - Feb 2005
Externally publishedYes

ASJC Scopus Subject Areas

  • Neurology
  • Clinical Neurology

Keywords

  • Controlled clinical trial
  • Interferon β-Ia
  • MRI
  • Once-weekly dosing
  • OWIMS study
  • Randomized
  • Relapse-related outcomes
  • Relapsing multiple sclerosis

Fingerprint

Dive into the research topics of 'Randomized study of once-weekly interferon β-la therapy in relapsing multiple sclerosis: Three-year data from the OWIMS study'. Together they form a unique fingerprint.

Cite this